Difference between revisions of "Team:Hong Kong UCCKE/HP/Silver"
Chuangusynwa (Talk | contribs) |
|||
| Line 6: | Line 6: | ||
<div class="row"><div class="col-md-8"> | <div class="row"><div class="col-md-8"> | ||
| − | <h3 class="sectiontitle" style="clear:both;">Interview with Dr.Pierre Chan </h3> | + | <h3 class="sectiontitle" style="clear:both;">Interview with Dr.Pierre Chan</h3> |
<div class="divider"></div> | <div class="divider"></div> | ||
| Line 28: | Line 28: | ||
</div> | </div> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<div class="col-md-4"> | <div class="col-md-4"> | ||
| + | <div style="text-align:left;"> | ||
| + | <a href="https://static.igem.org/mediawiki/2017/c/c9/T--Hong_Kong_UCCKE--interview.jpg" title="Interview with Dr.Pierre Chan" class="popup"><img src="https://static.igem.org/mediawiki/2017/c/c9/T--Hong_Kong_UCCKE--interview.jpg" style="height:auto; width:100%; max-width:500px; display: block;" alt="Interview with Dr.Pierre Chan"></a><span class="imgcaption">Interview with Dr.Pierre Chan</span> | ||
| + | </div> | ||
</div> | </div> | ||
| Line 47: | Line 41: | ||
</html> | </html> | ||
{{Hong_Kong_UCCKE/footer}} | {{Hong_Kong_UCCKE/footer}} | ||
| + | <html> | ||
| + | |||
| + | <style> | ||
| + | .mfp-bg,.mfp-wrap{position:fixed;left:0;top:0}.mfp-bg,.mfp-container,.mfp-wrap{height:100%;width:100%}.mfp-arrow:after,.mfp-arrow:before,.mfp-container:before,.mfp-figure:after{content:''}.mfp-bg{z-index:1042;overflow:hidden;background:#0b0b0b;opacity:.8}.mfp-wrap{z-index:1043;outline:0!important;-webkit-backface-visibility:hidden}.mfp-container{text-align:center;position:absolute;left:0;top:0;padding:0 8px;box-sizing:border-box}.mfp-container:before{display:inline-block;height:100%;vertical-align:middle}.mfp-align-top .mfp-container:before{display:none}.mfp-content{position:relative;display:inline-block;vertical-align:middle;margin:0 auto;text-align:left;z-index:1045}.mfp-ajax-holder .mfp-content,.mfp-inline-holder .mfp-content{width:100%;cursor:auto}.mfp-ajax-cur{cursor:progress}.mfp-zoom-out-cur,.mfp-zoom-out-cur .mfp-image-holder .mfp-close{cursor:-moz-zoom-out;cursor:-webkit-zoom-out;cursor:zoom-out}.mfp-zoom{cursor:pointer;cursor:-webkit-zoom-in;cursor:-moz-zoom-in;cursor:zoom-in}.mfp-auto-cursor .mfp-content{cursor:auto}.mfp-arrow,.mfp-close,.mfp-counter,.mfp-preloader{-webkit-user-select:none;-moz-user-select:none;user-select:none}.mfp-loading.mfp-figure{display:none}.mfp-hide{display:none!important}.mfp-preloader{color:#CCC;position:absolute;top:50%;width:auto;text-align:center;margin-top:-.8em;left:8px;right:8px;z-index:1044}.mfp-preloader a{color:#CCC}.mfp-close,.mfp-preloader a:hover{color:#FFF}.mfp-s-error .mfp-content,.mfp-s-ready .mfp-preloader{display:none}button.mfp-arrow,button.mfp-close{overflow:visible;cursor:pointer;background:0 0;border:0;-webkit-appearance:none;display:block;outline:0;padding:0;z-index:1046;box-shadow:none;touch-action:manipulation}.mfp-figure:after,.mfp-iframe-scaler iframe{box-shadow:0 0 8px rgba(0,0,0,.6);position:absolute;left:0}button::-moz-focus-inner{padding:0;border:0}.mfp-close{width:44px;height:44px;line-height:44px;position:absolute;right:0;top:0;text-decoration:none;text-align:center;opacity:.65;padding:0 0 18px 10px;font-style:normal;font-size:34px;font-family:Arial,Baskerville,monospace}.mfp-close:focus,.mfp-close:hover{opacity:1}.mfp-close:active{top:1px}.mfp-close-btn-in .mfp-close{color:#333}.mfp-iframe-holder .mfp-close,.mfp-image-holder .mfp-close{color:#FFF;right:-6px;text-align:right;padding-right:6px;width:100%}.mfp-counter{position:absolute;top:0;right:0;color:#CCC;font-size:14px;line-height:18px;white-space:nowrap}.mfp-figure,img.mfp-img{line-height:0}.mfp-arrow{position:absolute;opacity:.65;margin:-55px 0 0;top:50%;padding:0;width:90px;height:110px;-webkit-tap-highlight-color:transparent}.mfp-arrow:active{margin-top:-54px}.mfp-arrow:focus,.mfp-arrow:hover{opacity:1}.mfp-arrow:after,.mfp-arrow:before{display:block;width:0;height:0;position:absolute;left:0;top:0;margin-top:35px;margin-left:35px;border:inset transparent}.mfp-arrow:after{border-top-width:13px;border-bottom-width:13px;top:8px}.mfp-arrow:before{border-top-width:21px;border-bottom-width:21px;opacity:.7}.mfp-arrow-left{left:0}.mfp-arrow-left:after{border-right:17px solid #FFF;margin-left:31px}.mfp-arrow-left:before{margin-left:25px;border-right:27px solid #3F3F3F}.mfp-arrow-right{right:0}.mfp-arrow-right:after{border-left:17px solid #FFF;margin-left:39px}.mfp-arrow-right:before{border-left:27px solid #3F3F3F}.mfp-iframe-holder{padding-top:40px;padding-bottom:40px}.mfp-iframe-holder .mfp-content{line-height:0;width:100%;max-width:900px}.mfp-image-holder .mfp-content,img.mfp-img{max-width:100%}.mfp-iframe-holder .mfp-close{top:-40px}.mfp-iframe-scaler{width:100%;height:0;overflow:hidden;padding-top:56.25%}.mfp-iframe-scaler iframe{display:block;top:0;width:100%;height:100%;background:#000}.mfp-figure:after,img.mfp-img{width:auto;height:auto;display:block}img.mfp-img{box-sizing:border-box;padding:40px 0;margin:0 auto}.mfp-figure:after{top:40px;bottom:40px;right:0;z-index:-1;background:#444}.mfp-figure small{color:#BDBDBD;display:block;font-size:12px;line-height:14px}.mfp-figure figure{margin:0}.mfp-bottom-bar{margin-top:-36px;position:absolute;top:100%;left:0;width:100%;cursor:auto}.mfp-title{text-align:left;line-height:18px;color:#F3F3F3;word-wrap:break-word;padding-right:36px;font-size:16px !important;}.mfp-gallery .mfp-image-holder .mfp-figure{cursor:pointer}@media screen and (max-width:800px) and (orientation:landscape),screen and (max-height:300px){.mfp-img-mobile .mfp-image-holder{padding-left:0;padding-right:0}.mfp-img-mobile img.mfp-img{padding:0}.mfp-img-mobile .mfp-figure:after{top:0;bottom:0}.mfp-img-mobile .mfp-figure small{display:inline;margin-left:5px}.mfp-img-mobile .mfp-bottom-bar{background:rgba(0,0,0,.6);bottom:0;margin:0;top:auto;padding:3px 5px;position:fixed;box-sizing:border-box}.mfp-img-mobile .mfp-bottom-bar:empty{padding:0}.mfp-img-mobile .mfp-counter{right:5px;top:3px}.mfp-img-mobile .mfp-close{top:0;right:0;width:35px;height:35px;line-height:35px;background:rgba(0,0,0,.6);position:fixed;text-align:center;padding:0}}@media all and (max-width:900px){.mfp-arrow{-webkit-transform:scale(.75);transform:scale(.75)}.mfp-arrow-left{-webkit-transform-origin:0;transform-origin:0}.mfp-arrow-right{-webkit-transform-origin:100%;transform-origin:100%}.mfp-container{padding-left:6px;padding-right:6px}} | ||
| + | </style> | ||
| + | |||
| + | <script type="text/javascript" src="https://2017.igem.org/Template:Hong_Kong_UCCKE/magnificpopupjs? | ||
| + | action=raw&ctype=text/javascript"></script> | ||
| + | |||
| + | |||
| + | |||
| + | <script> | ||
| + | |||
| + | $('.popup').magnificPopup({ | ||
| + | type: 'image', | ||
| + | callbacks: { | ||
| + | open: function() { | ||
| + | $('#top_menu_14').fadeOut(); | ||
| + | }, | ||
| + | close: function() { | ||
| + | $('#top_menu_14').fadeIn(); | ||
| + | } | ||
| + | }, | ||
| + | image: { | ||
| + | titleSrc: 'title' | ||
| + | }, | ||
| + | });</script> | ||
| + | |||
| + | </html> | ||
Revision as of 06:45, 25 October 2017
Interview with Dr.Pierre Chan
Background
Rates of gout in Hong Kong are rising in the last decade, UCCKE igem team was honored to interview Dr. Pierre Chan, Hong Kong Special Administrative Region of China Legislative Councilor (Medical) on 30th August 2017 to know more about the current situation of this arthritis in the society. The topic of the interview was about gout and the application and concerns of gene therapy.
Gout in Hong Kong
Dr. Chan summarized the cause of gout of most patients in Hong Kong as “the diet of a middle-aged man during a hot pot dinner” beer, mushroom, meat and edible viscera. Most patients in Hong Kong suffer from swelling and pain in their joints after a hot pot dinner. In fact, more than 90 percent of them can benefit from colchicine and NSAID which is commonly offered by doctors. Others are recommend to use steroid alternatively. Steroid was considered harmful to the body by most of the patient in Hong Kong. However, Dr. Chan explained that steroid used in treating gout will not cause any potential harm to the patient considering that the amount of steroid used is very small. Commonly used painkiller, Colchicine and NSAID are very effective in terms of relieving pain in joints.For example, it can relieve the pain of a gout attack within an hour after the patient took the medicine. However, Dr. Chan described the medication as a sword as the effect and side effect coexist in a patient’s body which can affect one’s digestive system. For a long-term prevention of gout, Dr. Chan emphasized that diet restriction is the best way.
Gene Therapy
As gene therapy is still in a developing stage, Dr. Chan is not very supportive towards the application of gene therapy. He suggested that this technique will require at least 10-20 years of investigation in order to gain the reliability for the therapy. He quoted thalassemia, a single-gene disorder as an example to explain the difficulty of applying gene therapy to a patient. He believes that gene therapy will be an ideal way of treating diseases once the technique is fully developed.
Interview with Dr.Pierre Chan
